ITMCTR2100005212Recruiting未知
Real world study on adjuvant treatment of non-small cell lung cancer with commonly used anti-cancer traditional Chinese medicine injection
Beijing Hospital of Traditional Chinese Medicined0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational study
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •(1) Patients with primary lung cancer hospitalized in the oncology department of Beijing Traditional Chinese medicine hospital from January 1, 2016 to December 31, 2018 according to the standardized diagnosis and treatment guidelines;
- •(2) The patients were treated with platinum containing double drug chemotherapy for more than 2 cycles;
- •(3) Traditional Chinese medicine injection and Kang'ai injection were used simultaneously in chemotherapy.
Exclusion Criteria
- •At the same time, there are other primary malignant tumors; Lung tumor metastases from other sites to the lung; Pathological diagnosis was small cell lung cancer.
Investigators
Similar Trials
Completed
Phase 2
Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II studyColon cancerJPRN-UMIN000006742Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group195
Recruiting
Not Applicable
Clinical efficacy study of neoadjuvant therapy with intensity-modulated radiotherapy combined with S-1 for resectable pancreatic cancerpancreatic cancerJPRN-UMIN000046456Kyoto Katsura Hospital40
Completed
Not Applicable
The phase I/II study of the adjuvant therapy using alpha-galactosylceramide pulsed dendritic cells for patients with advanced high-grade salivary gland tumor followed by standard therpies.Salivary gland tumorJPRN-UMIN000024669Chiba University Hospital6
Completed
Phase 1
The phase I/II study of the adjuvant therapy using alpha-galactosylceramide pulsed antigen presenting cells for patients with high-grade salivary grand tumor followed by standard therpies.High-grade salivary grand tumorJPRN-UMIN000011509Department of Otorynolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University9
Completed
Early Phase 1
The Effectiveness of the adjuvant treatment with a compound of sedge plant, saffron and honey to conventional treatment for improvement of cognitive performance of patients with dementiaIRCT2016101030255N1Vice Chancellor for research of Isfahan University of Medical Sciences60